Thu, May 31, 2012 2:10 PM
Report on voting rights attached to shares and the share capital
According to rules on disclosing ordinary information a status report is issued on voting rights attached to shares and the share capital of the Company recorded on May 31, 2012.

Egis Pharmaceuticals PLC (the 'Company', having its headquarters at H-1106 Budapest, Keresztúri út 30-38.), in effort to meet the rules set in point (9) Section 54 of the modified Capital Market Act (CXX/2001), hereby publishes the following information on voting rights attached to its shares and on the share capital. Compositon of the share capital of the Company on May 31, 2012.

Related file

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox